BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 26782005)

  • 1. B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.
    Yoshizaki A
    J Dermatol; 2016 Jan; 43(1):39-45. PubMed ID: 26782005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
    Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
    Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal B lymphocyte activation and function in systemic sclerosis.
    Yoshizaki A; Sato S
    Ann Dermatol; 2015 Feb; 27(1):1-9. PubMed ID: 25673924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic roles of B lymphocytes in systemic sclerosis.
    Yoshizaki A
    Immunol Lett; 2018 Mar; 195():76-82. PubMed ID: 29307688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
    Hasegawa M
    J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [B cell abnormalities and autoantibody production in systemic sclerosis].
    Sato S
    Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr; 29(2):73-84. PubMed ID: 16651705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
    Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
    Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells in systemic sclerosis: a possible target for therapy.
    Bosello S; De Luca G; Tolusso B; Lama G; Angelucci C; Sica G; Ferraccioli G
    Autoimmun Rev; 2011 Aug; 10(10):624-30. PubMed ID: 21545850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse.
    Saito E; Fujimoto M; Hasegawa M; Komura K; Hamaguchi Y; Kaburagi Y; Nagaoka T; Takehara K; Tedder TF; Sato S
    J Clin Invest; 2002 Jun; 109(11):1453-62. PubMed ID: 12045259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B lymphocytes and systemic sclerosis.
    Fujimoto M; Sato S
    Curr Opin Rheumatol; 2005 Nov; 17(6):746-51. PubMed ID: 16224253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
    Yoshizaki A
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.
    Yoshizaki A; Iwata Y; Komura K; Ogawa F; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Tedder TF; Sato S
    Am J Pathol; 2008 Jun; 172(6):1650-63. PubMed ID: 18467694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.
    Tedder TF; Poe JC; Fujimoto M; Haas KM; Sato S
    Curr Dir Autoimmun; 2005; 8():55-90. PubMed ID: 15564717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.
    Sato S; Fujimoto M; Hasegawa M; Takehara K
    Arthritis Rheum; 2004 Jun; 50(6):1918-27. PubMed ID: 15188368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleosome in patients with systemic sclerosis: possible association with immunological abnormalities via abnormal activation of T and B cells.
    Yoshizaki A; Taniguchi T; Saigusa R; Fukasawa T; Ebata S; Numajiri H; Nakamura K; Yamashita T; Takahashi T; Toyama T; Asano Y; Tedder TF; Sato S
    Ann Rheum Dis; 2016 Oct; 75(10):1858-65. PubMed ID: 26567180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Frequency of Activated Switched Memory B Cells and Its Association With the Presence of Pulmonary Fibrosis in Diffuse Cutaneous Systemic Sclerosis Patients.
    Simon D; Balogh P; Erdő-Bonyár S; Böröcz K; Minier T; Czirják L; Berki T
    Front Immunol; 2021; 12():686483. PubMed ID: 34276673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative genetic variation in CD19 expression correlates with autoimmunity.
    Sato S; Hasegawa M; Fujimoto M; Tedder TF; Takehara K
    J Immunol; 2000 Dec; 165(11):6635-43. PubMed ID: 11086109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis.
    Tsuchiya N; Kuroki K; Fujimoto M; Murakami Y; Tedder TF; Tokunaga K; Takehara K; Sato S
    Arthritis Rheum; 2004 Dec; 50(12):4002-7. PubMed ID: 15593213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced non-switched memory B cell subsets cause imbalance in B cell repertoire in systemic sclerosis.
    Simon D; Balogh P; Bognár A; Kellermayer Z; Engelmann P; Németh P; Farkas N; Minier T; Lóránd V; Czirják L; Berki T
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):30-36. PubMed ID: 27056741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.